GLP-1 Medications and PCOS: What they fix, what they don't, and what order actually works

"Should I just go on a GLP-1?"

It is one of the most common questions being asked in PCOS circles right now, and it deserves a straight answer rather than a lecture. So here it is: for some women, a GLP-1 medication is a genuinely useful tool. It is not, on its own, a treatment for PCOS. Those two things are not in conflict, and understanding why will save you from either dismissing a useful medication out of principle, or expecting it to do a job it was never designed to do.

Can a GLP-1 medication treat PCOS?

A GLP-1 can meaningfully help if insulin resistance is your main driver, but it does not treat PCOS itself, since PCOS involves multiple hormone systems and a GLP-1 only addresses one of them. Here is why that distinction matters. For a large proportion of women with PCOS, insulin resistance sits underneath the whole picture. Your cells stop responding properly to insulin's signal, so your pancreas produces more of it to compensate. That excess insulin does two things that matter here: it drives your ovaries to overproduce androgens, and it makes fat storage, particularly around the abdomen, easier and fat loss harder. This is the biology behind why "eat less, move more" so often fails to shift weight for women with this presentation. The advice ignores the hormone driving the resistance in the first place.

GLP-1 receptor agonists work by mimicking a gut hormone that increases insulin sensitivity, slows gastric emptying, and reduces appetite. For someone with significant insulin resistance, that mechanism genuinely helps. In one clinical study of women with PCOS and obesity treated with semaglutide, close to 80 percent lost at least 5 percent of their body weight, with an average loss of around 11.5 kilograms over six months. Fasting insulin and HOMA-IR, a standard marker of insulin resistance, improved even in women who did not reach that weight loss threshold, and among those who responded to treatment, roughly 80 percent saw their cycles normalise. It is not surprising that many women on these medications report improved cycles alongside weight loss, because improving insulin sensitivity is directly relevant to PCOS physiology. What the research does not yet tell us is what happens to androgen levels directly, testosterone and DHEA-S were not reported in that data, which matters if your presentation is adrenal or inflammatory rather than insulin-driven.

There is also a practical piece worth knowing before this conversation goes any further. In New Zealand, Pharmac does not currently fund semaglutide (Wegovy) or tirzepatide (Mounjaro) for weight loss. The only GLP-1 medications funded here are dulaglutide and liraglutide, and only for type 2 diabetes. If a GLP-1 is part of your plan for PCOS specifically, you are almost certainly looking at a fully private-pay medication, which is worth factoring into the decision alongside the clinical picture.

Where it stops being the whole answer

Here is the part that gets missed in a lot of the current conversation: a GLP-1 addresses one driver, insulin resistance, but PCOS is a polyendocrine condition. It was not adrenal-driven androgen excess before you started the medication, and it will not become adrenal-driven after. If your presentation is adrenal type, or inflammatory type, or your DHEA-S is the main issue rather than insulin, a GLP-1 may do very little for your actual symptoms, even while showing up as "successful" on the scale.

There is also the sequencing problem. Weight loss on a GLP-1 without addressing the muscle and nutrient foundations underneath it can mean losing lean muscle mass alongside fat. That matters more for PCOS than for most conditions, because skeletal muscle functions as an endocrine organ, releasing signalling molecules that improve insulin sensitivity when you have enough of it. Lose muscle while losing weight, and you can end up with a lower number on the scale and a less favourable metabolic picture than when you started.

And then there is what happens if the medication stops. Without the underlying insulin resistance, nutrient status, and inflammatory drivers having been properly addressed, appetite and insulin resistance patterns commonly return once the medication is withdrawn, because the mechanism driving them was never resolved. It was suppressed.

None of this is an argument against these medications. It is an argument for using them as part of a sequence, not as the whole plan.

A root cause approach: test first, then decide where medication fits

The right starting point, with or without a GLP-1 in the picture, is the same: find out which version of PCOS you actually have before deciding what to do about it. That means:

• A full androgen panel, to see whether insulin, the adrenal glands, or inflammation is your primary driver

• Fasting insulin and glucose, since standard fasting glucose alone frequently misses insulin resistance that is already well established

• Assessment of nutrient status relevant to insulin signalling and muscle maintenance

• A protein and resistance training foundation, so that any weight change, medicated or not, preserves rather than depletes muscle

If insulin resistance is confirmed as a major driver and a GLP-1 is part of your plan, alongside your GP or specialist, the naturopathic role is to build the foundation that makes the medication work better and makes coming off it, if that is the plan, sustainable rather than a reset button. That means protein intake, resistance training, targeted nutrient support, and gut and inflammation management running the whole time you are on it, not started afterwards.

This is not naturopathy instead of medicine. It is naturopathy alongside your GP, doing the parts a prescription was never designed to do: identifying which type of PCOS you actually have, protecting your muscle, and building something that holds once the medication conversation changes.

Test, don't guess, whichever path you are considering.

If you are weighing up a GLP-1, or already on one and want to make sure the foundations are actually in place, book a clarity call and let's map out where you actually stand.